Medichem Becomes a B Corp Company for Its Commitment to Sustainability
02/07/2025
Barcelona, July 2, 2025 – The companies within the MEDICHEM Group, a developer and manufacturer of active pharmaceutical ingredients and finished dosage forms for the global generics industry, have earned B Corp certification, awarded by B Lab. With this recognition, Medichem joins a global movement of companies that meet high standards of social and environmental performance, transparency, and corporate accountability.
Medichem operates through its companies Medichem, S.A., Medichem Manufacturing Malta Ltd., Combino Pharm Malta Ltd., and Medichem Solutions S.L. By meeting the B Corp standards, the group reaffirms its purpose of generating a positive impact on society and the environment.
A Rigorous Evaluation Process and a Commitment to Sustainability and Continuous Improvement
B Corp standards assess performance across five key areas: Governance, Workers, Community, Environment, and Customers. To achieve certification, companies must score a minimum of 80 points, providing solid evidence of socially and environmentally responsible practices in areas such as energy supply, water and waste management, employee compensation, diversity, and corporate transparency. Medichem achieved a score of 98.4, significantly surpassing the required minimum and earning recognition for its excellence in sustainability.
Strong corporate governance and a responsible supply chain were key factors in attaining B Corp certification. Medichem demonstrated board diversity and independence, as well as transparency in performance and ethical business conduct, including responsible practices throughout its supply chain.
From an environmental perspective, Medichem has calculated its carbon footprint across scopes 1, 2, and 3, and implemented reduction strategies. The company is currently in the process of setting emissions reduction targets aligned with the Science Based Targets initiative (SBTi). It is also actively engaged in energy efficiency projects, circular economy initiatives, and responsible water use, further solidifying its commitment to sustainability and business excellence.
Recognition for the Team and Cross-Functional Collaboration
This achievement was made possible thanks to the coordinated efforts of Medichem’s Sustainability Committee and the cross-functional teams who have driven this transformation from across the organisation. Their dedication, commitment, and shared vision have been instrumental in embedding sustainability principles into the Group’s strategy and operations.
The Benefits of Being a B Corp
By becoming a B Corp, Medichem strengthens its position as a trusted partner in the pharmaceutical industry, gaining multiple advantages:
– Increased credibility and trust among clients, partners, and collaborators.
– Reinforced ESG strategy, aligning operations with high sustainability standards.
– Enhanced brand positioning and alignment with purpose, differentiating itself in the market with a responsible and transparent approach.
On its journey to B Corp certification, Medichem Group received advisory support from RS4, a consultancy specializing in business impact and active ESG management.
By joining the B Corp movement, Medichem Group becomes part of a global community of nearly 10,000 companies leading a new way of doing business—focused on sustainability, responsible innovation, and creating shared value for customers, partners, and society.
